[
  {
    "ts": "2026-01-06T10:30:00+00:00",
    "headline": "Big Pharma Has More Going for It Than Obesity Drugs",
    "summary": "Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.",
    "url": "https://www.wsj.com/health/pharma/big-pharma-has-more-going-for-it-than-obesity-drugs-35ffd102?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "718b31ea-161c-37e0-b9a9-30d517b0adda",
      "content": {
        "id": "718b31ea-161c-37e0-b9a9-30d517b0adda",
        "contentType": "STORY",
        "title": "Big Pharma Has More Going for It Than Obesity Drugs",
        "description": "",
        "summary": "Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.",
        "pubDate": "2026-01-06T10:30:00Z",
        "displayTime": "2026-01-06T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/718b31ea-161c-37e0-b9a9-30d517b0adda/big-pharma-has-more-going-for.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7RMo0RAoQIXBecVowGWgxA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0b65xm2vuQmoOxj8Df4WNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/big-pharma-has-more-going-for-it-than-obesity-drugs-35ffd102?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-06T13:00:15+00:00",
    "headline": "Is Bristol-Myers Squibb Company's (NYSE:BMY) 33% ROE Better Than Average?",
    "summary": "While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-companys-nyse-130015922.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3364d319-b214-3f2e-971b-937d3f0c5ee5",
      "content": {
        "id": "3364d319-b214-3f2e-971b-937d3f0c5ee5",
        "contentType": "STORY",
        "title": "Is Bristol-Myers Squibb Company's (NYSE:BMY) 33% ROE Better Than Average?",
        "description": "",
        "summary": "While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...",
        "pubDate": "2026-01-06T13:00:15Z",
        "displayTime": "2026-01-06T13:00:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-companys-nyse-130015922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-companys-nyse-130015922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]